Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arsenal of drugs available for treatment. The existing drugs have significant deficiencies so there is an urgent need for new and improved drugs. In the human host, Leishmania are obligate intracellular p...
Saved in:
Main Authors: | Andrea Nühs (Author), Manu De Rycker (Author), Sujatha Manthri (Author), Eamon Comer (Author), Christina A Scherer (Author), Stuart L Schreiber (Author), Jean-Robert Ioset (Author), David W Gray (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade.
by: Anton Simeonov, et al.
Published: (2008) -
High-throughput screening reveals novel mutations in spinal muscular atrophy patients
by: Ruiping Zhang, et al.
Published: (2020) -
High-Throughput Screening for Drug Discovery
Published: (2022) -
Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi.
by: Elizabeth Bilsland, et al.
Published: (2016) -
Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish
by: Giancarlo eBruni, et al.
Published: (2014)